Consumption of Feed Supplemented with Oat Beta-Glucan as a Chemopreventive Agent against Colon Cancerogenesis in Rats

• Published in: Nutrients 2024-04, Vol.16 (8), p.1125
• Main Authors: Harasym, Joanna, Dziendzikowska, Katarzyna, Kopiasz, Łukasz, Wilczak, Jacek, Sapierzyński, Rafał, Gromadzka-Ostrowska, Joanna
• Format: Article
• Language: English
• Subjects: Animal Feed; Animals; Anticarcinogenic Agents - pharmacology; Antioxidants; Antioxidants - pharmacology; Avena - chemistry; Azoxymethane; beta-Glucans - administration & dosage; beta-Glucans - pharmacology; bioactive compounds; Biomarkers; Cancer; Colon - drug effects; Colon - metabolism; Colon - pathology; Colonic Neoplasms - prevention & control; Colorectal cancer; Colorectal Neoplasms - prevention & control; Costs (Law); Dietary fiber; Dietary Supplements; Disease Models, Animal; Gene expression; Health aspects; Immunohistochemistry; Laboratories; Male; Molecular weight; oat beta-glucan; oxidative stress; Oxidative Stress - drug effects; Polyphenols; Prevention; Proteins; Rats; Rats, Sprague-Dawley; Rodents; Wnt Signaling Pathway - drug effects; Women
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu16081125

Colorectal cancer (CRC) accounts for 30% of all cancer cases worldwide and is the second leading cause of cancer-related deaths. CRC develops over a long period of time, and in the early stages, pathological changes can be mitigated through nutritional interventions using bioactive plant compounds. Our study aims to determine the effect of highly purified oat beta-glucan on an animal CRC model. The study was performed on forty-five male Sprague-Dawley rats with azoxymethane-induced early-stage CRC, which consumed feed containing 1% or 3% low molar mass oat beta-glucan (OBG) for 8 weeks. In the large intestine, morphological changes, CRC signaling pathway genes (RT-PCR), and proteins (Western blot, immunohistochemistry) expression were analyzed. Whole blood hematology and blood redox status were also performed. Results indicated that the histologically confirmed CRC condition led to a downregulation of the WNT/β-catenin pathway, along with alterations in oncogenic and tumor suppressor gene expression. However, OBG significantly modulated these effects, with the 3% OBG showing a more pronounced impact. Furthermore, CRC rats exhibited elevated levels of oxidative stress and antioxidant enzyme activity in the blood, along with decreased white blood cell and lymphocyte counts. Consumption of OBG at any dose normalized these parameters. The minimal effect of OBG in the physiological intestine and the high activity in the pathological condition suggest that OBG is both safe and effective in early-stage CRC.